RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity
- 24 October 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 311 (3), 786-792
- https://doi.org/10.1016/j.bbrc.2003.10.060
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- RNA interference may be more potent than antisense RNA in human cancer cell linesClinical and Experimental Pharmacology and Physiology, 2003
- FAK regulates biological processes important for the pathogenesis of cancerCancer and Metastasis Reviews, 2003
- Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivoBiochemical and Biophysical Research Communications, 2002
- Biochemical signals and biological responses elicited by the focal adhesion kinaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2001
- Regulated Expression of Focal Adhesion Kinase-Related Nonkinase, the Autonomously Expressed C-Terminal Domain of Focal Adhesion KinaseMolecular and Cellular Biology, 1999
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumorsAnnals of Surgical Oncology, 1994
- Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK.Molecular and Cellular Biology, 1993
- pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.Proceedings of the National Academy of Sciences, 1992
- Binding and Biological Effects of Tumor Necrosis Factor and Gamma Interferon in Human Pancreatic Carcinoma CellsPancreas, 1990